| Title : Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) - Furusawa_2023_Diabetes.Obes.Metab__ |
| Author(s) : Furusawa S , Nomoto H , Yokoyama H , Suzuki Y , Tsuzuki A , Takahashi K , Miya A , Kameda H , Cho KY , Takeuchi J , Nagai S , Taneda S , Kurihara Y , Nakamura A , Atsumi T |
| Ref : Diabetes Obes Metab , : , 2023 |
| Abstract : |
| PubMedSearch : Furusawa_2023_Diabetes.Obes.Metab__ |
| PubMedID: 38073422 |
| Title : Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) - Furusawa_2023_Diabetes.Obes.Metab__ |
| Author(s) : Furusawa S , Nomoto H , Yokoyama H , Suzuki Y , Tsuzuki A , Takahashi K , Miya A , Kameda H , Cho KY , Takeuchi J , Nagai S , Taneda S , Kurihara Y , Nakamura A , Atsumi T |
| Ref : Diabetes Obes Metab , : , 2023 |
| Abstract : |
| PubMedSearch : Furusawa_2023_Diabetes.Obes.Metab__ |
| PubMedID: 38073422 |
| Title : Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) - Furusawa_2023_Diabetes.Obes.Metab__ |
| Author(s) : Furusawa S , Nomoto H , Yokoyama H , Suzuki Y , Tsuzuki A , Takahashi K , Miya A , Kameda H , Cho KY , Takeuchi J , Nagai S , Taneda S , Kurihara Y , Nakamura A , Atsumi T |
| Ref : Diabetes Obes Metab , : , 2023 |
| Abstract : |
| PubMedSearch : Furusawa_2023_Diabetes.Obes.Metab__ |
| PubMedID: 38073422 |